ストックスクリーナーアプリを入手
18.08
0.89%
0.16
Crescent Biopharma Inc (CBIO) 最新ニュース
The numbers behind Crescent Bio (CBIO) stock nobody talks about (Technical Weakness) 2026-05-03 - Newser
Crude Oil Down 3%; Chevron Posts Mixed Q1 Results - Benzinga
Stifel Maintains Crescent Biopharma(CBIO.US) With Buy Rating, Cuts Target Price to $30 - Moomoo
Nasdaq Jumps Over 1%; Exxon Mobil Posts Upbeat Revenue - Benzinga
Crescent Biopharma Down Over 16%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk - Moomoo
Crescent Biopharma Inc (CBIO) - MSN
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Cytokinetics (CYTK) and Crescent Biopharma (CBIO) - The Globe and Mail
CBIO Price Today: Crescent Biopharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Wedbush Maintains Crescent Biopharma(CBIO.US) With Buy Rating, Maintains Target Price $27 - Moomoo
A Quick Look at Today's Ratings for Crescent Biopharma(CBIO.US), With a Forecast Between $27 to $35 - Moomoo
Crescent Biopharma: Q1 Earnings Snapshot - Barchart.com
Crescent Biopharma (CBIO) registers 19.58M ordinary shares for resale - Stock Titan
Crescent Biopharma (NASDAQ: CBIO) posts Q1 2026 loss and oncology pipeline update - Stock Titan
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights - ChartMill
Crescent Biopharma (CBIO) Q1 2026 results show $23.3M loss and $189M cash - Stock Titan
Crescent Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MSN Money - MSN
Crescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200-Day Moving AverageShould You Sell? - MarketBeat
Crescent Biopharma Grants Equity Inducement Awards to New Employees as Part of 2025 Incentive Plan - Quiver Quantitative
Crescent Biopharma Announces Grants of Inducement Awards - ChartMill
New Crescent hires receive stock options priced at Nasdaq's $25.70 close - Stock Titan
Stifel Initiates Coverage of Crescent Biopharma (CBIO) with Buy Recommendation - MSN
Crescent Bio (CBIO) Stock: Is It Losing Momentum | Q4 2025: Better Than ExpectedWall Street Picks - Xã Châu Thành
Analysts Are Bullish on These Healthcare Stocks: Guardant Health (GH), Crescent Biopharma (CBIO) - The Globe and Mail
CRESCENT BIOPHARMA, INC. ($CBIO) CEO & Director 2025 Pay Revealed - Quiver Quantitative
Form DEFA14A CRESCENT BIOPHARMA, INC. - StreetInsider
Crescent Biopharma (NASDAQ: CBIO) outlines 2026 AGM votes on board, pay and auditor - Stock Titan
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Piper Sandler Maintains Crescent Biopharma(CBIO.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) vs. Crescent Biopharma (NASDAQ:CBIO) Head to Head Review - Defense World
Crescent Biopharma Stock On Fire: Up 86% With 7-Day Winning Streak - Trefis
Crescent Biopharma Stock Surges 86%, With A 7-Day Winning Spree - Trefis
CBIO Shows Strength: Technical Breakout Imminent - Newser
Crescent Biopharma Stock Surges 85%, With A 6-Day Winning Spree - Trefis
Crescent Biopharma Stock Rockets 85% With 6-Day Winning Streak - Trefis
Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Three new Crescent Biopharma hires get stock options at $13.50 - Stock Titan
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Crescent Biopharma, Inc. (CBIO) Fundamental Analysis - meyka.com
Why Is Crescent Biopharma, Inc. (CBIO) Stock Down Today? - Meyka
Crescent Biopharma, Inc.: Fundamental Analysis and Financial Ratings | | US38000Q2012 - marketscreener.com
CBIO PE Ratio & Valuation, Is CBIO Overvalued - Intellectia AI
Crescent Biopharma (NASDAQ: CBIO) registers 19.58M resale shares from private placement - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Upgraded to Hold at Wall Street Zen - MarketBeat
HC Wainwright Has Optimistic Outlook of CBIO Q1 Earnings - Defense World
Two Crescent Biopharma employees granted 45,675 stock options - Stock Titan
HC Wainwright Issues Optimistic Estimate for CBIO Earnings - MarketBeat
GLYC SEC FilingsGlycomimetics 10-K, 10-Q, 8-K Forms - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Given New $22.00 Price Target at HC Wainwright - Defense World
Crescent Biopharma (NASDAQ: CBIO) registers 19.58M resale shares after $185M placement - Stock Titan
CBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Price Target Lowered to $22.00 at HC Wainwright - MarketBeat
H.C. Wainwright cuts Crescent Biopharma stock price target to $22 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Crescent Biopharma stock price target to $22 - Investing.com Australia
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):